Venrock Healthcare Capital Partners III
Major shareholder at Lycia Therapeutics · 7 reported transactions in 1 company · latest trade Oct 27, 2026
Their record
No purchases old enough to measure yet.
Their trades
Bought | Oct 27, 2026 | Oct 27, 2026 close $26.11 → Oct 29, 2026 close $27.73. S&P 500 +0.3% over the same days. | ||
Bought | Oct 27, 2026 | Oct 27, 2026 close $26.11 → Oct 29, 2026 close $27.73. S&P 500 +0.3% over the same days. | ||
Bought | Oct 26, 2026 | Oct 26, 2026 close $28.85 → Oct 29, 2026 close $27.73. S&P 500 +0.9% over the same days. | ||
Bought | Oct 26, 2026 | Oct 26, 2026 close $28.85 → Oct 29, 2026 close $27.73. S&P 500 +0.9% over the same days. | ||
Bought | Oct 23, 2026 | Oct 23, 2026 close $30.00 → Oct 29, 2026 close $27.73. S&P 500 +1.6% over the same days. | ||
Bought | Oct 23, 2026 | Oct 23, 2026 close $30.00 → Oct 29, 2026 close $27.73. S&P 500 +1.6% over the same days. |
BoughtLycia Therapeutics
$833.8K
Oct 27, 2026 close $26.11 → Oct 29, 2026 close $27.73. S&P 500 +0.3% over the same days.
BoughtLycia Therapeutics
$225.6K
Oct 27, 2026 close $26.11 → Oct 29, 2026 close $27.73. S&P 500 +0.3% over the same days.
BoughtLycia Therapeutics
$222.8K
Oct 26, 2026 close $28.85 → Oct 29, 2026 close $27.73. S&P 500 +0.9% over the same days.
BoughtLycia Therapeutics
$35M
Oct 26, 2026 close $28.85 → Oct 29, 2026 close $27.73. S&P 500 +0.9% over the same days.
BoughtLycia Therapeutics
$741K
Oct 23, 2026 close $30.00 → Oct 29, 2026 close $27.73. S&P 500 +1.6% over the same days.
BoughtLycia Therapeutics
$630.7K
Oct 23, 2026 close $30.00 → Oct 29, 2026 close $27.73. S&P 500 +1.6% over the same days.